Detail page

Knowledge Web

Person

Brigitte Schlegelberger (1956-)

Ärztin

Name	Brigitte Schlegelberger
Time	1956- (Date of birth and death)
Place	München (Geburtsort) Hannover (Wirkungsort) Deutschland
Gender	weiblich
Academic degree	Prof. Dr. med.
Profession	Ärztin (characteristic profession) Fachärztin
Variant	B. Schlegelberger
Related	Medizinische Hochschule Hannover Medizinische Hochschule Hannover. Institut für Zell- und Molekularpathologie Medizinische Hochschule Hannover. Institut für Humangenetik (Direktorin) (2014-) Medizin (Studienfach)
Further information	Fachärztin für Humangenetik; Direktorin des Instituts für Zell- und Molekularpathologie der Medizinischen Hochschule Hannover, nach der Fusion mit dem Institut für Humangenetik, Direktorin des Instituts für Humangenetik der Medizinischen Hochschule Hannover
Record type	Person
GND-Identifier	133666115
Record ID	133666115
Involved in show all Recurrent DNMT3B rearrangements are associated with unfavorable outcome in dicentric (9;20)-positive pediatric BCP-ALL Einfluss der microRNA-449a auf die Autophagie im triple-negativen Brustkrebs Impact of PPM1D mutations in patients with myelodysplastic syndrome and deletion of chromosome 5q Systematic genetic analysis of pediatric patients with autoinflammatory diseases MiR-129-5p exerts Wnt signaling-dependent tumor-suppressive functions in hepatocellular carcinoma by directly targeting hepatoma-derived growth factor HDGF Correction to: Functional classification of RUNX1 variants in familial platelet disorder with associated myeloid malignancies Review of guidelines for the identification and clinical care of patients with genetic predisposition for hematological malignancies Functional classification of RUNX1 variants in familial platelet disorder with associated myeloid malignancies Functional classification of RUNX1 variants in familial platelet disorder with associated myeloid malignancies Review of guidelines for the identification and clinical care of patients with genetic predisposition for hematological malignancies Correction: High-risk additional chromosomal abnormalities at low blast counts herald death by CML Dihydropyrimidine Dehydrogenase Testing prior to Treatment with 5-Fluorouracil, Capecitabine, and Tegafur: A Consensus Paper An experimental study for characterization of the porcine SRY gene Dihydropyrimidine dehydrogenase testing prior to treatment with 5-Fluorouracil, Capecitabine, and Tegafur : a consensus paper Establishment and characterization of a sclerosing spindle cell rhabdomyosarcoma cell line with a complex genomic profile Über die epigenetische Regulation der miRNA-129-5p und ihre Auswirkungen auf die Genexpression von ETV1 im hepatozellulären Karzinom Imatinib dose reduction in major molecular response of chronic myeloid leukemia: results from the German Chronic Myeloid Leukemia-Study IV Constitutional SAMD9L mutations cause familial myelodysplastic syndrome and transient monosomy 7 Mutational Spectrum of Fanconi Anemia Associated Myeloid Neoplasms Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease Die Schnittentbindung aus der Sicht der Patientin, eine Analyse der Folgen für die Frau : vergleichende Unters. an 240 schnittentbundenen und 240 vaginal entbundenen Frauen

Please note

The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link:

Katalog der Deutschen Nationalbibliothek

Brigitte Schlegelberger (1956-)

Recurrent DNMT3B rearrangements are associated with unfavorable outcome in dicentric (9;20)-positive pediatric BCP-ALL

Einfluss der microRNA-449a auf die Autophagie im triple-negativen Brustkrebs

Impact of PPM1D mutations in patients with myelodysplastic syndrome and deletion of chromosome 5q

Systematic genetic analysis of pediatric patients with autoinflammatory diseases

MiR-129-5p exerts Wnt signaling-dependent tumor-suppressive functions in hepatocellular carcinoma by directly targeting hepatoma-derived growth factor HDGF

Correction to: Functional classification of RUNX1 variants in familial platelet disorder with associated myeloid malignancies

Review of guidelines for the identification and clinical care of patients with genetic predisposition for hematological malignancies

Functional classification of RUNX1 variants in familial platelet disorder with associated myeloid malignancies

Functional classification of RUNX1 variants in familial platelet disorder with associated myeloid malignancies

Review of guidelines for the identification and clinical care of patients with genetic predisposition for hematological malignancies

Correction: High-risk additional chromosomal abnormalities at low blast counts herald death by CML

Dihydropyrimidine Dehydrogenase Testing prior to Treatment with 5-Fluorouracil, Capecitabine, and Tegafur: A Consensus Paper

An experimental study for characterization of the porcine SRY gene

Dihydropyrimidine dehydrogenase testing prior to treatment with 5-Fluorouracil, Capecitabine, and Tegafur : a consensus paper

Establishment and characterization of a sclerosing spindle cell rhabdomyosarcoma cell line with a complex genomic profile

Über die epigenetische Regulation der miRNA-129-5p und ihre Auswirkungen auf die Genexpression von ETV1 im hepatozellulären Karzinom

Imatinib dose reduction in major molecular response of chronic myeloid leukemia: results from the German Chronic Myeloid Leukemia-Study IV

Constitutional SAMD9L mutations cause familial myelodysplastic syndrome and transient monosomy 7

Mutational Spectrum of Fanconi Anemia Associated Myeloid Neoplasms

Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease

Die Schnittentbindung aus der Sicht der Patientin, eine Analyse der Folgen für die Frau : vergleichende Unters. an 240 schnittentbundenen und 240 vaginal entbundenen Frauen